News | RIVM

New test has no added value in Lyme disease of the central nervous system

Active Lyme disease of the central nervous system cannot be detected with an ELISpot test.

Dutch collaboration in One Health European Joint Programme (EJP)

RIVM, Wageningen Bioveterinary Research (WBVR) and the Netherlands Centre for One Health (NCOH) are involved in a recently granted One Health European Joint Programme which will start in January 20

Lyme disease costs EUR 20 million annually

The societal costs of Lyme disease have been determined for the Netherlands for the first time. The disease appears to cost nearly EUR 20 million each year.

Livestock farming affects pulmonary function in local residents

COPD patients living near livestock farms suffer more complications.

Lab tests alone not conclusive for diagnosis of Lyme disease

Lyme disease can cause a variety of complaints in patients. Laboratory tests for the disease can support medical practitioners in making a diagnosis but are not necessarily conclusive.

Eating less salt can prevent tens of thousands of heart attacks and strokes

Lowering the amount of salt in processed foods or choosing low-salt alternatives can lead to substantial health benefits when it comes to cardiovascular disease.

Major loss of healthy life years due to long-term complaints after Lyme disease

The Netherlands is the first country where the burden of disease due to Lyme disease has been determined.